These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
861 related items for PubMed ID: 27716272
1. The histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathways. Hrgovic I, Doll M, Kleemann J, Wang XF, Zoeller N, Pinter A, Kippenberger S, Kaufmann R, Meissner M. BMC Cancer; 2016 Sep 30; 16(1):763. PubMed ID: 27716272 [Abstract] [Full Text] [Related]
2. P53-dependent antiproliferative and pro-apoptotic effects of trichostatin A (TSA) in glioblastoma cells. Bajbouj K, Mawrin C, Hartig R, Schulze-Luehrmann J, Wilisch-Neumann A, Roessner A, Schneider-Stock R. J Neurooncol; 2012 May 30; 107(3):503-16. PubMed ID: 22270849 [Abstract] [Full Text] [Related]
3. Breast cancer cells are arrested at different phases of the cell cycle following the re-expression of ARHI. Zuo X, Qin Y, Zhang X, Ning Q, Shao S, Luo M, Yuan N, Huang S, Zhao X. Oncol Rep; 2014 May 30; 31(5):2358-64. PubMed ID: 24676336 [Abstract] [Full Text] [Related]
4. The role of p21(waf1/cip1) and p27(Kip1) in HDACi-mediated tumor cell death and cell cycle arrest in the Eμ-myc model of B-cell lymphoma. Newbold A, Salmon JM, Martin BP, Stanley K, Johnstone RW. Oncogene; 2014 Nov 20; 33(47):5415-23. PubMed ID: 24292681 [Abstract] [Full Text] [Related]
5. Superior activity of a new histone deacetylase inhibitor (ZYJ-34c) in inhibiting growth of human leukemia cells by inducing p21WAF1 expression and cell cycle arrest. Yang H, Xu W, Li Y, Lan P, Zhang J, Zhang Y, Zhang C. Anticancer Drugs; 2014 Aug 20; 25(7):767-77. PubMed ID: 24686006 [Abstract] [Full Text] [Related]
6. Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells. Park H, Lee YJ, Kim TH, Lee J, Yoon S, Choi WS, Myung CS, Kim HS. Int J Mol Med; 2008 Nov 20; 22(5):605-11. PubMed ID: 18949380 [Abstract] [Full Text] [Related]
7. ERK inhibition enhances TSA-induced gastric cancer cell apoptosis via NF-κB-dependent and Notch-independent mechanism. Yao J, Qian CJ, Ye B, Zhang X, Liang Y. Life Sci; 2012 Sep 04; 91(5-6):186-93. PubMed ID: 22781708 [Abstract] [Full Text] [Related]
8. Histone Deacetylase Inhibitor Trichostatin A Suppresses Cell Proliferation and Induces Apoptosis by Regulating the PI3K/AKT Signalling Pathway in Gastric Cancer Cells. An X, Wei Z, Ran B, Tian H, Gu H, Liu Y, Cui H, Zhu S. Anticancer Agents Med Chem; 2020 Sep 04; 20(17):2114-2124. PubMed ID: 32593284 [Abstract] [Full Text] [Related]
9. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter. Yokota T, Matsuzaki Y, Miyazawa K, Zindy F, Roussel MF, Sakai T. Oncogene; 2004 Jul 08; 23(31):5340-9. PubMed ID: 15107822 [Abstract] [Full Text] [Related]
10. The histone-deacetylase inhibitor Trichostatin A blocks proliferation and triggers apoptotic programs in hepatoma cells. Herold C, Ganslmayer M, Ocker M, Hermann M, Geerts A, Hahn EG, Schuppan D. J Hepatol; 2002 Feb 08; 36(2):233-40. PubMed ID: 11830335 [Abstract] [Full Text] [Related]
12. Histone deacetylase inhibitor trichostatin A inhibits the growth of bladder cancer cells through induction of p21WAF1 and G1 cell cycle arrest. Li GC, Zhang X, Pan TJ, Chen Z, Ye ZQ. Int J Urol; 2006 May 08; 13(5):581-6. PubMed ID: 16771729 [Abstract] [Full Text] [Related]
13. Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line. Duo J, Ma Y, Wang G, Han X, Zhang C. DNA Cell Biol; 2013 Apr 08; 32(4):156-64. PubMed ID: 23451817 [Abstract] [Full Text] [Related]
14. Histone deacetylase inhibitors SAHA and sodium butyrate block G1-to-S cell cycle progression in neurosphere formation by adult subventricular cells. Zhou Q, Dalgard CL, Wynder C, Doughty ML. BMC Neurosci; 2011 May 26; 12():50. PubMed ID: 21615950 [Abstract] [Full Text] [Related]
19. Induction of apoptosis of lung and esophageal cancer cells treated with the combination of histone deacetylase inhibitor (trichostatin A) and protein kinase C inhibitor (calphostin C). Maxhimer JB, Reddy RM, Zuo J, Cole GW, Schrump DS, Nguyen DM. J Thorac Cardiovasc Surg; 2005 Jan 26; 129(1):53-63. PubMed ID: 15632825 [Abstract] [Full Text] [Related]
20. Inhibition of mTOR signalling potentiates the effects of trichostatin A in human gastric cancer cell lines by promoting histone acetylation. Sun DF, Zhang YJ, Tian XQ, Chen YX, Fang JY. Cell Biol Int; 2014 Jan 26; 38(1):50-63. PubMed ID: 24030871 [Abstract] [Full Text] [Related] Page: [Next] [New Search]